Why the study?
Limited evidence is available regarding the role, severity evaluation, necessity, and optimal timing of coronary revascularization in patients undergoing TAVI.
How should coronary artery disease be evaluated and managed, including the necessity and timing of PCI, in patients undergoing TAVI?
How should coronary artery disease be evaluated and managed, including the necessity and timing of PCI, in patients undergoing TAVI?
This review summarizes the epidemiology, diagnostic tools, and management options for concomitant coronary artery disease in patients undergoing TAVI, highlighting the ongoing debate regarding the necessity and optimal timing of PCI.
Coronary artery disease (CAD) is a frequent finding in patients with aortic stenosis (AS). Concomitant coronary artery bypass and aortic valve replacement is considered the gold standard treatment in surgical candidates. However, limited evidence is available regarding the role of coronary revascularization in patients undergoing transcatheter aortic valve implantation (TAVI). How to evaluate CAD severity in patients with AS, whether percutaneous coronary intervention (PCI) needs to be performed and what is the timing for revascularization to minimize procedural risks, remains matters of debate. The aim of this review is to summarize epidemiology, diagnostic tools and possible options for CAD management in patients undergoing TAVI with specific focus on the pros and the cons of the different timing of PCI.
No takes yet. Share an insight, caveat, or question.
Massussi et al. (2023) conducted a review in Coronary artery disease and aortic stenosis. Coronary revascularization (PCI) was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: